{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T01:20:48Z","timestamp":1791854448144,"version":"4.3.4"},"reference-count":128,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T00:00:00Z","timestamp":1685664000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"US National Institutes of Health","award":["R01AG065240"],"award-info":[{"award-number":["R01AG065240"]}]},{"name":"US National Institutes of Health","award":["R01NS115903"],"award-info":[{"award-number":["R01NS115903"]}]},{"name":"US National Institutes of Health","award":["R01AG076051"],"award-info":[{"award-number":["R01AG076051"]}]},{"name":"US National Institutes of Health","award":["RF1AG074346"],"award-info":[{"award-number":["RF1AG074346"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Motor Neuron Diseases (MND) are neurological disorders characterized by a loss of varying motor neurons resulting in decreased physical capabilities. Current research is focused on hindering disease progression by determining causes of motor neuron death. Metabolic malfunction has been proposed as a promising topic when targeting motor neuron loss. Alterations in metabolism have also been noted at the neuromuscular junction (NMJ) and skeletal muscle tissue, emphasizing the importance of a cohesive system. Finding metabolism changes consistent throughout both neurons and skeletal muscle tissue could pose as a target for therapeutic intervention. This review will focus on metabolic deficits reported in MNDs and propose potential therapeutic targets for future intervention.<\/jats:p>","DOI":"10.3390\/cells12111536","type":"journal-article","created":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T08:50:31Z","timestamp":1685695831000},"page":"1536","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Altered Metabolism in Motor Neuron Diseases: Mechanism and Potential Therapeutic Target"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1251-8571","authenticated-orcid":false,"given":"Cassandra","family":"Barone","sequence":"first","affiliation":[{"name":"Department of Physiology and Biophysics, School of Medicine Case Western Reserve University, Cleveland, OH 44106-4970, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9578-3890","authenticated-orcid":false,"given":"Xin","family":"Qi","sequence":"additional","affiliation":[{"name":"Department of Physiology and Biophysics, School of Medicine Case Western Reserve University, Cleveland, OH 44106-4970, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,6,2]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Meo, G., Ferraro, P.M., Cillerai, M., Gemelli, C., Cabona, C., Zaottini, F., Roccatagliata, L., Villani, F., Schenone, A., and Caponnetto, C. (2022). MND Phenotypes Differentiation: The Role of Multimodal Characterization at the Time of Diagnosis. Life, 12.","DOI":"10.3390\/life12101506"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Scaricamazza, S., Salvatori, I., Ferri, A., and Valle, C. (2021). Skeletal Muscle in ALS: An Unappreciated Therapeutic Opportunity?. Cells, 10.","DOI":"10.3390\/cells10030525"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1007\/s12035-021-02658-6","article-title":"Neuromuscular Junction Dysfunction in Amyotrophic Lateral Sclerosis","volume":"59","author":"Verma","year":"2022","journal-title":"Mol. Neurobiol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3389\/fnana.2016.00006","article-title":"Neuromuscular Junctions as Key Contributors and Therapeutic Targets in Spinal Muscular Atrophy","volume":"10","author":"Boido","year":"2016","journal-title":"Front. Neuroanat."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Costamagna, D., Casters, V., Beltr\u00e0, M., Sampaolesi, M., Van Campenhout, A., Ortibus, E., Desloovere, K., and Duelen, R. (2022). Autologous iPSC-Derived Human Neuromuscular Junction to Model the Pathophysiology of Hereditary Spastic Paraplegia. Cells, 11.","DOI":"10.3390\/cells11213351"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s40478-022-01402-y","article-title":"Neuromuscular junction pathology is correlated with differential motor unit vulnerability in spinal and bulbar muscular atrophy","volume":"10","author":"Molotsky","year":"2022","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1056\/NEJMra1603471","article-title":"Amyotrophic Lateral Sclerosis","volume":"377","author":"Brown","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1136\/jnnp-2019-322541","article-title":"Primary lateral sclerosis: Consensus diagnostic criteria","volume":"91","author":"Turner","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Messina, S., and Sframeli, M. (2020). New Treatments in Spinal Muscular Atrophy: Positive Results and New Challenges. J. Clin. Med., 9.","DOI":"10.3390\/jcm9072222"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"171","DOI":"10.4103\/2152-7806.169561","article-title":"A comprehensive review of amyotrophic lateral sclerosis","volume":"6","author":"Zarei","year":"2015","journal-title":"Surg. Neurol. Int."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1111\/ene.14393","article-title":"Amyotrophic lateral sclerosis: A clinical review","volume":"27","author":"Masrori","year":"2020","journal-title":"Eur. J. Neurol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.neubiorev.2017.01.045","article-title":"The neuropathological signature of bulbar-onset ALS: A systematic review","volume":"75","author":"Shellikeri","year":"2017","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.chest.2018.06.035","article-title":"Respiratory Failure in Amyotrophic Lateral Sclerosis","volume":"155","author":"Niedermeyer","year":"2019","journal-title":"Chest"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/brain\/124.10.2000","article-title":"Respiratory muscle strength and ventilatory failure in amyotrophic lateral sclerosis","volume":"124","author":"Lyall","year":"2001","journal-title":"Brain"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/WCO.0000000000000730","article-title":"Epidemiology of amyotrophic lateral sclerosis: An update of recent literature","volume":"32","author":"Longinetti","year":"2019","journal-title":"Curr. Opin. Neurol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"310","DOI":"10.3109\/17482960802566824","article-title":"Prognostic factors in ALS: A critical review","volume":"10","author":"Chio","year":"2009","journal-title":"Amyotroph Lateral Scler"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nature20413","article-title":"Decoding ALS: From genes to mechanism","volume":"539","author":"Taylor","year":"2016","journal-title":"Nature"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.3389\/fnins.2019.01310","article-title":"ALS Genetics, Mechanisms, and Therapeutics: Where Are We Now?","volume":"13","author":"Mejzini","year":"2019","journal-title":"Front Neurosci."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Pansarasa, O., Bordoni, M., Diamanti, L., Sproviero, D., Gagliardi, S., and Cereda, C. (2018). SOD1 in Amyotrophic Lateral Sclerosis: \u201cAmbivalent\u201d Behavior Connected to the Disease. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19051345"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1177\/1073858414561795","article-title":"SOD1 Function and Its Implications for Amyotrophic Lateral Sclerosis Pathology: New and Renascent Themes","volume":"21","author":"Saccon","year":"2015","journal-title":"Neuroscientist"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1126\/science.1134108","article-title":"Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis","volume":"314","author":"Neumann","year":"2006","journal-title":"Science"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1038\/emboj.2010.143","article-title":"ALS-associated fused in sarcoma (FUS) mutations disrupt Transportin-mediated nuclear import","volume":"29","author":"Dormann","year":"2010","journal-title":"EMBO J."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nrneurol.2016.182","article-title":"Gene discovery in amyotrophic lateral sclerosis: Implications for clinical management","volume":"13","author":"Veldink","year":"2017","journal-title":"Nat. Rev. Neurol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/mus.20728","article-title":"Primary lateral sclerosis","volume":"35","author":"Singer","year":"2007","journal-title":"Muscle Nerve"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/00005053-194510000-00002","article-title":"Primary Lateral Sclerosis A Distinct Clinical Entity","volume":"102","author":"Stark","year":"1945","journal-title":"J. Nerv. Ment. Dis."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1001\/archneurpsyc.1943.02290140011001","article-title":"Amyotrophic Lateral Sclerosis and Related Conditions A Clinical Analysis","volume":"49","author":"Swank","year":"1943","journal-title":"Arch. Neurol. Psychiatry"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1093\/brain\/115.2.495","article-title":"Primary lateral sclerosis: Clinical features, neuropathology and diagnostic criteria","volume":"115","author":"Pringle","year":"1992","journal-title":"Brain"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"e2231","DOI":"10.1212\/WNL.0000000000011771","article-title":"Natural History of \u201cPure\u201d Primary Lateral Sclerosis","volume":"96","author":"Hassan","year":"2021","journal-title":"Neurology"},{"key":"ref_29","first-page":"11","article-title":"Does primary lateral sclerosis exist? A study of 20 patients and a review of the literature","volume":"124","author":"Maisonobe","year":"2001","journal-title":"Brain"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.ncl.2015.07.007","article-title":"Primary Lateral Sclerosis","volume":"33","author":"Statland","year":"2015","journal-title":"Neurol. Clin."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1080\/21678421.2020.1837177","article-title":"Genetics of primary lateral sclerosis","volume":"21","author":"Silani","year":"2020","journal-title":"Amyotroph. Lateral Scler. Front. Degener."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/ng1001-160","article-title":"The gene encoding alsin, a protein with three guanine-nucleotide exchange factor domains, is mutated in a form of recessive amyotrophic lateral sclerosis","volume":"29","author":"Yang","year":"2001","journal-title":"Nat. Genet."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1002\/ana.23641","article-title":"Loss of ERLIN2 function leads to juvenile primary lateral sclerosis","volume":"72","author":"Bohlega","year":"2012","journal-title":"Ann. Neurol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1016\/S0140-6736(08)60921-6","article-title":"Spinal muscular atrophy","volume":"371","author":"Lunn","year":"2008","journal-title":"Lancet"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s13023-017-0671-8","article-title":"Prevalence, incidence and carrier frequency of 5q-linked spinal muscular atrophy-a literature review","volume":"12","author":"Verhaart","year":"2017","journal-title":"Orphanet. J. Rare Dis."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0092-8674(95)90460-3","article-title":"Identification and characterization of a spinal muscular atrophy-determining gene","volume":"80","author":"Lefebvre","year":"1995","journal-title":"Cell"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s004390100473","article-title":"SMN gene duplication and the emergence of the SMN2 gene occurred in distinct hominids: SMN2 is unique to Homo sapiens","volume":"108","author":"Rochette","year":"2001","journal-title":"Hum. Genet."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1093\/hmg\/4.10.1927","article-title":"Molecular analysis of candidate genes on chromosome 5q13 in autosomal recessive spinal muscular atrophy: Evidence of homozygous deletions of the SMN gene in unaffected individuals","volume":"4","author":"Hahnen","year":"1995","journal-title":"Hum. Mol. Genet."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1177\/0883073807305673","article-title":"Spinal Muscular Atrophy: Clinical Classification and Disease Heterogeneity","volume":"22","author":"Russman","year":"2007","journal-title":"J. Child Neurol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ncl.2015.07.004","article-title":"Spinal Muscular Atrophy","volume":"33","author":"Kolb","year":"2015","journal-title":"Neurol. Clin."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S1090-3798(99)80015-4","article-title":"Prenatal onset spinal muscular atrophy","volume":"3","author":"Macleod","year":"1999","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"eRC4011","DOI":"10.1590\/s1679-45082018rc4011","article-title":"X-linked spinal and bulbar muscular atrophy (Kennedy\u2019s disease): The first case described in the Brazilian Amazon","volume":"16","author":"Alves","year":"2018","journal-title":"Einstein"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s13023-020-01366-z","article-title":"The French national protocol for Kennedy\u2019s disease (SBMA): Consensus diagnostic and management recommendations","volume":"15","author":"Pradat","year":"2020","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"844","DOI":"10.3389\/fneur.2018.00844","article-title":"Biomarkers of Spinal and Bulbar Muscle Atrophy (SBMA): A Comprehensive Review","volume":"9","author":"Querin","year":"2018","journal-title":"Front. Neurol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1136\/jnnp.69.2.150","article-title":"Hereditary spastic paraparesis: A review of new developments","volume":"69","author":"McDermott","year":"2000","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"660714","DOI":"10.3389\/fnins.2021.660714","article-title":"Hereditary Spastic Paraplegia and Future Therapeutic Directions: Beneficial Effects of Small Compounds Acting on Cellular Stress","volume":"15","author":"Gumeni","year":"2021","journal-title":"Front. Neurosci."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Chen, J., Zhao, Z., Shen, H., Bing, Q., Li, N., Guo, X., and Hu, J. (2022). Genetic origin of patients having spastic paraplegia with or without other neurologic manifestations. BMC Neurol., 22.","DOI":"10.1186\/s12883-022-02708-z"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s00401-013-1115-8","article-title":"Hereditary spastic paraplegia: Clinico-pathologic features and emerging molecular mechanisms","volume":"126","author":"Fink","year":"2013","journal-title":"Acta Neuropathol."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Meyyazhagan, A., and Orlacchio, A. (2022). Hereditary Spastic Paraplegia: An Update. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23031697"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"690899","DOI":"10.3389\/fmolb.2021.690899","article-title":"Insights into Clinical, Genetic, and Pathological Aspects of Hereditary Spastic Paraplegias: A Comprehensive Overview","volume":"8","author":"Elsayed","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1136\/jnnp-2017-317887","article-title":"Hypermetabolism in ALS is associated with greater functional decline and shorter survival","volume":"89","author":"Steyn","year":"2018","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Quessada, C., Bouscary, A., Ren\u00e9, F., Valle, C., Ferri, A., Ngo, S.T., and Loeffler, J.P. (2021). Skeletal Muscle Metabolism: Origin or Prognostic Factor for Amyotrophic Lateral Sclerosis (ALS) Development?. Cells, 10.","DOI":"10.3390\/cells10061449"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s00401-018-1835-x","article-title":"Energy metabolism in ALS: An underappreciated opportunity?","volume":"135","author":"Vandoorne","year":"2018","journal-title":"Acta Neuropathol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s13578-020-00511-2","article-title":"CNS glucose metabolism in Amyotrophic Lateral Sclerosis: A therapeutic target?","volume":"11","author":"Tefera","year":"2021","journal-title":"Cell Biosci."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.tins.2013.07.001","article-title":"Sugar for the brain: The role of glucose in physiological and pathological brain function","volume":"36","author":"Mergenthaler","year":"2013","journal-title":"Trends Neurosci."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"585","DOI":"10.3389\/fneur.2019.00585","article-title":"Ketone Bodies in Neurological Diseases: Focus on Neuroprotection and Underlying Mechanisms","volume":"10","author":"Yang","year":"2019","journal-title":"Front. Neurol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/(SICI)1098-1136(199709)21:1<2::AID-GLIA2>3.0.CO;2-C","article-title":"Glucose transporter proteins in brain: Delivery of glucose to neurons and glia","volume":"21","author":"Vannucci","year":"1997","journal-title":"Glia"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"365","DOI":"10.3389\/fendo.2020.00365","article-title":"The Role of the Pentose Phosphate Pathway in Diabetes and Cancer","volume":"11","author":"Ge","year":"2020","journal-title":"Front. Endocrinol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"17757","DOI":"10.1073\/pnas.1010459107","article-title":"Regional aerobic glycolysis in the human brain","volume":"107","author":"Vaishnavi","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1111\/brv.12140","article-title":"The return of metabolism: Biochemistry and physiology of the pentose phosphate pathway","volume":"90","author":"Stincone","year":"2015","journal-title":"Biol. Rev. Camb. Philos. Soc."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/s41467-019-13668-3","article-title":"Mitochondrial TCA cycle metabolites control physiology and disease","volume":"11","author":"Chandel","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"101674","DOI":"10.1016\/j.redox.2020.101674","article-title":"Mitochondrial electron transport chain: Oxidative phosphorylation, oxidant production, and methods of measurement","volume":"37","author":"Braganza","year":"2020","journal-title":"Redox Biol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3389\/fnmol.2020.00162","article-title":"The TOR Pathway at the Neuromuscular Junction: More Than a Metabolic Player?","volume":"13","author":"Castets","year":"2020","journal-title":"Front. Mol. Neurosci."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"610964","DOI":"10.3389\/fnmol.2020.610964","article-title":"The Neuromuscular Junction in Health and Disease: Molecular Mechanisms Governing Synaptic Formation and Homeostasis","volume":"13","author":"Cruz","year":"2020","journal-title":"Front. Mol. Neurosci."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.cophys.2018.04.007","article-title":"Causes and consequences of age-related changes at the neuromuscular junction","volume":"4","author":"Ham","year":"2018","journal-title":"Curr. Opin. Physiol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.neuron.2017.09.055","article-title":"Mitostasis in Neurons: Maintaining Mitochondria in an Extended Cellular Architecture","volume":"96","author":"Misgeld","year":"2017","journal-title":"Neuron"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"jcs234492","DOI":"10.1242\/jcs.234492","article-title":"In vitro compartmental system underlines the contribution of mitochondrial immobility to the ATP supply in the NMJ","volume":"132","author":"Altman","year":"2019","journal-title":"J. Cell Sci."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1152\/physrev.00038.2012","article-title":"Exercise, GLUT4, and skeletal muscle glucose uptake","volume":"93","author":"Richter","year":"2013","journal-title":"Physiol. Rev."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/s42255-020-0251-4","article-title":"Skeletal muscle energy metabolism during exercise","volume":"2","author":"Hargreaves","year":"2020","journal-title":"Nat. Metab."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3389\/fphys.2019.00026","article-title":"Effect of Exercise on Fatty Acid Metabolism and Adipokine Secretion in Adipose Tissue","volume":"10","author":"Mika","year":"2019","journal-title":"Front. Physiol."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Ignatieva, E., Smolina, N., Kostareva, A., and Dmitrieva, R. (2021). Skeletal Muscle Mitochondria Dysfunction in Genetic Neuromuscular Disorders with Cardiac Phenotype. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22147349"},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Hyatt, H.W., and Powers, S.K. (2021). Mitochondrial Dysfunction Is a Common Denominator Linking Skeletal Muscle Wasting Due to Disease, Aging, and Prolonged Inactivity. Antioxidants, 10.","DOI":"10.3390\/antiox10040588"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/17482960802295192","article-title":"High metabolic level in patients with familial amyotrophic lateral sclerosis","volume":"10","author":"Funalot","year":"2009","journal-title":"Amyotroph. Lateral Scler."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"13292","DOI":"10.1038\/s41598-022-16229-9","article-title":"Correlation of weight and body composition with disease progression rate in patients with amyotrophic lateral sclerosis","volume":"12","author":"Li","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"7821672","DOI":"10.1155\/2017\/7821672","article-title":"What is \u201cHyper\u201d in the ALS Hypermetabolism?","volume":"2017","author":"Ferri","year":"2017","journal-title":"Mediat. Inflamm"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ensci.2017.01.001","article-title":"Regional glucose hypometabolic spread within the primary motor cortex is associated with amyotrophic lateral sclerosis disease progression: A fluoro-deoxyglucose positron emission tomography study","volume":"6","author":"Endo","year":"2017","journal-title":"Eneurologicalsci"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1212\/WNL.0000000000000792","article-title":"Functional pattern of brain FDG-PET in amyotrophic lateral sclerosis","volume":"83","author":"Pagani","year":"2014","journal-title":"Neurology"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1046\/j.0022-3042.2001.00731.x","article-title":"Mitochondrial DNA and respiratory chain function in spinal cords of ALS patients","volume":"80","author":"Wiedemann","year":"2002","journal-title":"J. Neurochem."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1111\/bph.12476","article-title":"Mitochondrial dysfunction in amyotrophic lateral sclerosis-a valid pharmacological target?","volume":"171","author":"Muyderman","year":"2014","journal-title":"Br. J. Pharm."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"679","DOI":"10.3389\/fnins.2020.00679","article-title":"Mitochondrial Dysfunction, Neurogenesis, and Epigenetics: Putative Implications for Amyotrophic Lateral Sclerosis Neurodegeneration and Treatment","volume":"14","author":"Henriques","year":"2020","journal-title":"Front. Neurosci."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"132933","DOI":"10.1016\/j.neulet.2017.06.052","article-title":"The role of mitochondria in amyotrophic lateral sclerosis","volume":"710","author":"Smith","year":"2019","journal-title":"Neurosci. Lett."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1097\/00001756-200008030-00032","article-title":"Mitochondrial DNA deletion mutation levels are elevated in ALS brains","volume":"11","author":"Dhaliwal","year":"2000","journal-title":"Neuroreport"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/nen.0b013e31802c396b","article-title":"Mitochondrial Alterations in the Spinal Cord of Paitents With Sporadic Amyotrophic Lateral Sclerosis","volume":"66","author":"Sasaki","year":"2007","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/0304-3940(96)12314-4","article-title":"Ultrastructual study of synapses in the anterior horn neurons of patients with amyotrophic lateral sclerosis","volume":"204","author":"Sasaki","year":"1996","journal-title":"Neurosci. Lett."},{"key":"ref_85","first-page":"41","article-title":"Oxidative stress and mitochondrial damage: Importance in non-SOD1 ALS","volume":"9","author":"Valle","year":"2015","journal-title":"Front. Cell Neurosci."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.nbd.2006.01.001","article-title":"Bioenergetic abnormalities in discrete cerebral motor pathways presage spinal cord pathology in the G93A SOD1 mouse model of ALS","volume":"22","author":"Browne","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"29626","DOI":"10.1074\/jbc.M203065200","article-title":"Mutated Human SOD1 Causes Dysfunction of Oxidative Phosphorylation in Mitochondria of Transgenic Mice","volume":"277","author":"Mattiazzi","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.genm.2010.11.010","article-title":"Effects of gender in amyotrophic lateral sclerosis","volume":"7","author":"McCombe","year":"2010","journal-title":"Gend. Med."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40478-015-0271-6","article-title":"Early and gender-specific differences in spinal cord mitochondrial function and oxidative stress markers in a mouse model of ALS","volume":"4","author":"Cacabelos","year":"2016","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Wang, P., Deng, J., Dong, J., Liu, J., Bigio, E.H., Mesulam, M., Wang, T., Sun, L., Wang, L., and Lee, A.Y.-L. (2019). TDP-43 induces mitochondrial damage and activates the mitochondrial unfolded protein response. PLOS Genet., 15.","DOI":"10.1371\/journal.pgen.1007947"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"4287","DOI":"10.1038\/s41598-022-08068-5","article-title":"Mitochondrial dysregulation occurs early in ALS motor cortex with TDP-43 pathology and suggests maintaining NAD(+) balance as a therapeutic strategy","volume":"12","author":"Gautam","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"101","DOI":"10.7554\/eLife.45114","article-title":"Glycolysis upregulation is neuroprotective as a compensatory mechanism in ALS","volume":"8","author":"Manzo","year":"2019","journal-title":"Elife"},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Loganathan, S., Wilson, B.A., Carey, S.B., Manzo, E., Joardar, A., Ugur, B., and Zarnescu, D.C. (2022). TDP-43 Proteinopathy Causes Broad Metabolic Alterations including TCA Cycle Intermediates and Dopamine Levels in Drosophila Models of ALS. Metabolites, 12.","DOI":"10.3390\/metabo12020101"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1038\/s41418-020-00664-0","article-title":"ALS motor neurons exhibit hallmark metabolic defects that are rescued by SIRT3 activation","volume":"28","author":"Hor","year":"2020","journal-title":"Cell Death Differ."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/j.neurobiolaging.2013.11.025","article-title":"Superoxide dismutase 1 mutation in a cellular model of amyotrophic lateral sclerosis shifts energy generation from oxidative phosphorylation to glycolysis","volume":"35","author":"Allen","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"4147","DOI":"10.1038\/s41467-019-12099-4","article-title":"Differentiation but not ALS mutations in FUS rewires motor neuron metabolism","volume":"10","author":"Vandoorne","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"101468","DOI":"10.1016\/j.molmet.2022.101468","article-title":"Neurons undergo pathogenic metabolic reprogramming in models of familial ALS","volume":"60","author":"Riechers","year":"2022","journal-title":"Mol. Metab."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"5844","DOI":"10.1007\/s12035-019-1485-6","article-title":"Impaired Pentose Phosphate Pathway in the Spinal Cord of the hSOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis","volume":"56","author":"Tefera","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1001\/archneurol.2010.128","article-title":"Mitochondrial Respiratory Chain Dysfunction in Muscle From Patients With Amyotrophic Lateral Sclerosis","volume":"67","author":"Crugnola","year":"2010","journal-title":"Arch. Neurol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.nbd.2012.08.015","article-title":"Disruption of skeletal muscle mitochondrial network genes and miRNAs in amyotrophic lateral sclerosis","volume":"49","author":"Russell","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Luo, G., Yi, J., Ma, C., Xiao, Y., Yi, F., Yu, T., and Zhou, J. (2013). Defective Mitochondrial Dynamics Is an Early Event in Skeletal Muscle of an Amyotrophic Lateral Sclerosis Mouse Model. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0082112"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1074\/jbc.M109.041319","article-title":"Hyperactive Intracellular Calcium Signaling Associated with Localized Mitochondrial Defects in Skeletal Muscle of an Animal Model of Amyotrophic Lateral Sclerosis","volume":"285","author":"Zhou","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_103","first-page":"4","article-title":"The Stripe of Primary Lateral Sclerosis Focal Primary Motor Cortex Hypometabolism Seen on Fluordeozyglucose F18 Positron Emission Tomography","volume":"67","author":"Claasse","year":"2010","journal-title":"Arch. Neurol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"3395","DOI":"10.1093\/hmg\/ddw262","article-title":"Motor neuron mitochondrial dysfunction in spinal muscular atrophy","volume":"25","author":"Miller","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"3539","DOI":"10.1038\/s41598-019-40118-3","article-title":"Gene expression analysis reveals early dysregulation of disease pathways and links Chmp7 to pathogenesis of spinal and bulbar muscular atrophy","volume":"9","author":"Malik","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jns.2016.02.007","article-title":"Mitochondrial dysfunction in hereditary spastic paraparesis with mutations in DDHD1\/SPG28","volume":"362","author":"Mignarri","year":"2016","journal-title":"J. Neurol. Sci."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"820","DOI":"10.3389\/fnins.2020.00820","article-title":"Mitochondrial Function in Hereditary Spastic Paraplegia: Deficits in SPG7 but Not SPAST Patient-Derived Stem Cells","volume":"14","author":"Wali","year":"2020","journal-title":"Front. Neurosci."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"4016","DOI":"10.1093\/brain\/awab488","article-title":"Inhibiting mitochondrial fission rescues degeneration in hereditary spastic paraplegia neurons","volume":"145","author":"Chen","year":"2022","journal-title":"Brain"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1007\/s00415-015-7721-8","article-title":"Dissociated lower limb muscle involvement in amyotrophic lateral sclerosis","volume":"262","author":"Simon","year":"2015","journal-title":"J. Neurol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"17786","DOI":"10.1038\/s41598-019-54372-y","article-title":"Dissociated lower limb muscle involvement in amyotrophic lateral sclerosis and its differential diagnosis value","volume":"9","author":"Hu","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1136\/jnnp.73.2.199","article-title":"Detection of preclinical motor neuron loss in SOD1 mutation carrier using motor unit number estimation","volume":"73","author":"Aggarwal","year":"2002","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.phrs.2018.09.008","article-title":"ROS-related mitochondrial dysfunction in skeletal muscle of an ALS mouse model during the disease progression","volume":"138","author":"Xiao","year":"2018","journal-title":"Pharmacol. Res."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"526","DOI":"10.15252\/emmm.201404433","article-title":"A metabolic switch toward lipid use in glycolytic muscle is an early pathologic event in a mouse model of amyotrophic lateral sclerosis","volume":"7","author":"Palamiuc","year":"2015","journal-title":"EMBO Mol. Med."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"332","DOI":"10.3389\/fnmol.2017.00332","article-title":"Specific Physical Exercise Improves Energetic Metabolism in the Skeletal Muscle of Amyotrophic-Lateral-Sclerosis Mice","volume":"10","author":"Desseille","year":"2017","journal-title":"Front. Mol. Neurosci."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1136\/jnnp.71.5.615","article-title":"Primary lateral sclerosis: Clinical, neurophysiological, and magnetic resonance findings","volume":"71","author":"Jager","year":"2001","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_116","doi-asserted-by":"crossref","unstructured":"Zilio, E., Piano, V., and Wirth, B. (2022). Mitochondrial Dysfunction in Spinal Muscular Atrophy. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms231810878"},{"key":"ref_117","first-page":"66","article-title":"Mitochondrial dysfunction in Kennedy\u2019s disease: A new pharmacological target?","volume":"3","author":"Wang","year":"2015","journal-title":"Ann. Transl. Med."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"112","DOI":"10.3109\/21678421.2015.1089910","article-title":"Mitochondrial implications in bulbospinal muscular atrophy (Kennedy disease)","volume":"17","author":"Finsterer","year":"2015","journal-title":"Amyotroph. Lateral Scler. Front. Degener."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"369284","DOI":"10.1155\/2012\/369284","article-title":"Current Status of Treatment of Spinal and Bulbar Muscular Atrophy","volume":"2012","author":"Tanaka","year":"2012","journal-title":"Neural Plast."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.ajhg.2012.11.001","article-title":"Alteration of Fatty-Acid-Metabolizing Enzymes Affects Mitochondrial Form and Function in Hereditary Spastic Paraplegia","volume":"91","author":"Tesson","year":"2012","journal-title":"Am. J. Hum. Genet."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1083\/jcb.200304112","article-title":"Loss of m-AAA protease in mitochondria causes complex I deficiency and increased sensitivity to oxidative stress in hereditary spastic paraplegia","volume":"163","author":"Atorino","year":"2003","journal-title":"J. Cell Biol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/s41419-018-0365-8","article-title":"Loss of the Drosophila m-AAA mitochondrial protease paraplegin results in mitochondrial dysfunction, shortened lifespan, and neuronal and muscular degeneration","volume":"9","author":"Pareek","year":"2018","journal-title":"Cell Death Dis."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1093\/brain\/awu060","article-title":"Mutations in the SPG7 gene cause chronic progressive external ophthalmoplegia through disordered mitochondrial DNA maintenance","volume":"137","author":"Pfeffer","year":"2014","journal-title":"Brain"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1091\/mbc.e13-03-0170","article-title":"Interaction between AP-5 and the hereditary spastic paraplegia proteins SPG11 and SPG15","volume":"24","author":"Hirst","year":"2013","journal-title":"Mol. Biol. Cell"},{"key":"ref_125","doi-asserted-by":"crossref","unstructured":"Khamaysa, M., and Pradat, P.-F. (2022). Status of ALS Treatment, Insights into Therapeutic Challenges and Dilemmas. J. Pers. Med., 12.","DOI":"10.3390\/jpm12101601"},{"key":"ref_126","first-page":"789","article-title":"A Novel Drp1 inhibitor diminishes aberrant mitochondrial fission and neurotoxicity","volume":"126","author":"Qi","year":"2013","journal-title":"J. Cell Sci."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.cmet.2012.03.019","article-title":"Elevated PGC-1\u03b1 Activity Sustains Mitochondrial Biogenesis and Muscle Function without Extending Survival in a Mouse Model of Inherited ALS","volume":"15","author":"Parone","year":"2012","journal-title":"Cell Metab."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1111\/bph.15738","article-title":"Repurposing of Trimetazidine for amyotrophic lateral sclerosis: A study in SOD1(G93A) mice","volume":"179","author":"Scaricamazza","year":"2022","journal-title":"Br. J. Pharmacol."}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/12\/11\/1536\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:48:03Z","timestamp":1760125683000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/12\/11\/1536"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,2]]},"references-count":128,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2023,6]]}},"alternative-id":["cells12111536"],"URL":"https:\/\/doi.org\/10.3390\/cells12111536","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,2]]}}}